These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29225246)

  • 1. Acute Arterial Thrombosis during Postoperative Adjuvant Cisplatin-based Chemotherapy for Completely Resected Lung Adenocarcinoma.
    Sato C; Okuda K; Tamiya H; Yamamoto K; Hoshina K; Narumoto O; Urushiyama H; Noguchi S; Amano Y; Watanabe K; Mitani A; Kage H; Tanaka G; Yamauchi Y; Takai D; Nagase T
    Intern Med; 2018 Feb; 57(4):557-561. PubMed ID: 29225246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide.
    Cool RM; Herrington JD; Wong L
    Pharmacotherapy; 2002 Sep; 22(9):1200-4. PubMed ID: 12222560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial thrombosis after chemotherapy with cisplatin, vinblastine and methotrexate.
    Molloy RG; Welch GC; Drury JK; Abel BJ
    Br J Clin Pract; 1995; 49(1):50-1. PubMed ID: 7742194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
    Kenmotsu H; Niho S; Ito T; Ishikawa Y; Noguchi M; Tada H; Sekine I; Watanabe S; Yoshimura M; Yamamoto N; Oshita F; Kubota K; Nagai K
    Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant chemotherapy for non-small cell lung cancer].
    Okamoto T; Ichinose Y
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):1985-90. PubMed ID: 17197740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split-dose cisplatin and vinorelbine as adjuvant chemotherapy for completely resected non-small cell lung cancer.
    Hirai F; Seto T; Shimokawa M; Inamasu E; Toyozawa R; Toyokawa G; Yoshida T; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
    Anticancer Res; 2014 Feb; 34(2):927-31. PubMed ID: 24511034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative adjuvant therapy in combined lung cancer treatment].
    Cicenas S; Piscikas DA; Jakubauskiene R
    Medicina (Kaunas); 2004; 40 Suppl 1():156-60. PubMed ID: 15079128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases.
    Mizugaki H; Fujiwara Y; Yamamoto N; Yagishita S; Kitazono S; Tanaka A; Horinouchi H; Kanda S; Nokihara H; Tsuta K; Asamura H; Tamura T
    Jpn J Clin Oncol; 2014 Sep; 44(9):835-40. PubMed ID: 25097183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
    Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA
    J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer.
    Kato H; Tsuboi M; Kato Y; Ikeda N; Okunaka T; Hamada C
    Int J Clin Oncol; 2005 Jun; 10(3):157-64. PubMed ID: 15990962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postoperative adjuvant chemotherapy for non-small cell lung cancer].
    Okamoto T; Ichinose Y
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):765-9. PubMed ID: 15984513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy.
    Koriyama H; Ishii G; Yoh K; Neri S; Morise M; Umemura S; Matsumoto S; Niho S; Ohmatsu H; Tsuboi M; Goto K; Ochiai A
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1163-70. PubMed ID: 25446816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
    Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
    J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment.
    Ramsden K; Laskin J; Ho C
    Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):394-400. PubMed ID: 25800720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma.
    Koh Y; Jang B; Jeon YK; Kim TM; Lee SH; Kim DW; Chung DH; Kim YT; Kim YW; Heo DS
    Jpn J Clin Oncol; 2011 Apr; 41(4):548-54. PubMed ID: 21247966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized adjuvant chemotherapy for surgically resected lung cancer and the roles of biomarkers.
    Ikeda N; Nagase S; Ohira T
    Ann Thorac Cardiovasc Surg; 2009 Jun; 15(3):144-9. PubMed ID: 19597387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of platinum combination chemotherapy re-challenge for relapsed patients with non-small-cell lung cancer after postoperative adjuvant chemotherapy of cisplatin plus vinorelbine.
    Imai H; Shukuya T; Yoshino R; Muraki K; Mori K; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Tomizawa Y; Takahashi T; Takahashi K; Saito R; Yamamoto N
    Chemotherapy; 2013; 59(4):307-13. PubMed ID: 24480845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive Conversion of PD-L1 Expression After Treatments with Chemotherapy and Nivolumab.
    Haratake N; Toyokawa G; Tagawa T; Kozuma Y; Matsubara T; Takamori S; Akamine T; Yamada Y; Oda Y; Maehara Y
    Anticancer Res; 2017 Oct; 37(10):5713-5717. PubMed ID: 28982891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.